<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2182-5173</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Medicina Geral e Familiar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Med Geral Fam]]></abbrev-journal-title>
<issn>2182-5173</issn>
<publisher>
<publisher-name><![CDATA[Associação Portuguesa de Medicina Geral e Familiar]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2182-51732022000100010</article-id>
<article-id pub-id-type="doi">10.32385/rpmgf.v38i1.13047</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[The role of a structured intervention on the deprescribing of benzodiazepines in a geriatric population managed in primary care]]></article-title>
<article-title xml:lang="pt"><![CDATA[Papel de uma intervenção estruturada na prescrição racional e desprescrição de benzodiazepinas na população geriátrica em cuidados primários]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cardoso]]></surname>
<given-names><![CDATA[Carlos Seiça]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rebelo-Marques]]></surname>
<given-names><![CDATA[Alexandre]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Loureiro]]></surname>
<given-names><![CDATA[Mariana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveiros]]></surname>
<given-names><![CDATA[Bárbara]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[Carlos Fontes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,USF Condeixa  ]]></institution>
<addr-line><![CDATA[Condeixa-a-Nova ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade de Coimbra Faculdade de Medicina ]]></institution>
<addr-line><![CDATA[Coimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Centro Hospitalar e Universitário de Coimbra Departamento de Psiquiatria ]]></institution>
<addr-line><![CDATA[Coimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,USF Fernando Namora  ]]></institution>
<addr-line><![CDATA[Condeixa-a-Nova ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidade de Coimbra Faculdade de Medicina Laboratory of Biostatistics and Medical Informatics]]></institution>
<addr-line><![CDATA[Coimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Universidade de Coimbra Faculdade de Medicina Coimbra Institute for Clinical and Biomedical Research]]></institution>
<addr-line><![CDATA[Coimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af7">
<institution><![CDATA[,Universidade de Coimbra Faculdade de Medicina Laboratório de Farmacologia e Terapêutica Experimental]]></institution>
<addr-line><![CDATA[Coimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>28</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>02</month>
<year>2022</year>
</pub-date>
<volume>38</volume>
<numero>1</numero>
<fpage>10</fpage>
<lpage>15</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2182-51732022000100010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2182-51732022000100010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2182-51732022000100010&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Benzodiazepines (BDZ) are widely used to control symptoms in insomnia and anxiety disorders. In the geriatric population, the concerns related to these treatments are higher, and, in addition to the possibility of causing daytime sleepiness, there is also evidence of an association with the increased risk of falls, cognitive decline, and delirium. In this context, it is important to study and evaluate strategies for rational prescribing and deprescribing of BDZ, avoiding prolonged/chronic use whenever it is clinically unnecessary, as well as developing guidelines to manage these therapeutic interventions. Our primary objective was to evaluate the effectiveness of a compound intervention in the rational prescribing/deprescribing of BDZ in geriatric patients managed in primary health care.  Methods:  Randomized clinical trial involving two Family Health Units (FHU), attending to test the effectiveness of a compound intervention to improve BDZ prescribing in patients older than 65 years.  Conclusion:  After 9 months the chance of not having a prescription for BDZ is, on average, 1,004 times higher (about 0.4%) in the FHU where there was an intervention than in the control, demonstrating that the intervention can be useful. We believe that other studies, methodologically optimized, may be an important contribution to help solve this problem.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  As benzodiazepinas (BDZ) são amplamente utilizadas para controlar os sintomas na insónia e nas perturbações de ansiedade. Na população geriátrica, as preocupações relacionadas com estes tratamentos são maiores, sendo que, além da possibilidade de causarem sonolência diurna, existe ainda evidência de associação com o aumento do risco de quedas, declínio cognitivo e delirium. Neste contexto surge a necessidade de estudar e avaliar estratégias para prescrição racional e desprescrição de BDZ, evitando utilização prolongada/crónica sempre que clinicamente desnecessária, bem como desenvolvimento de guidelines para apoiar estas intervenções terapêuticas. Este estudo teve como objetivo primário avaliar a eficácia de uma intervenção composta na prescrição racional/desprescrição de BDZ na população geriátrica acompanhada em cuidados de saúde primários.  Métodos:  Ensaio clínico aleatorizado envolvendo duas Unidades de Saúde Familiar (USF) do mesmo centro de saúde, com vista a testar a eficácia de uma intervenção composta na melhoria do perfil de prescrição de BDZ em indivíduos com mais de 65 anos.  Conclusão:  Após nove meses a probabilidade de não existir prescrição de BDZ é, em média, 1.004 vezes maior (cerca de 0,4%) na USF onde existiu intervenção do que na USF controlo e, portanto, demostrando que a intervenção pode ser benéfica. Acredita-se que outros estudos, metodologicamente otimizados, poderão ser um contributo importante para ajudar a resolver este problema.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Deprescription]]></kwd>
<kwd lng="en"><![CDATA[Benzodiazepines]]></kwd>
<kwd lng="en"><![CDATA[Hypnotic drugs]]></kwd>
<kwd lng="en"><![CDATA[Geriatrics]]></kwd>
<kwd lng="en"><![CDATA[Primary care.]]></kwd>
<kwd lng="pt"><![CDATA[Desprescrição]]></kwd>
<kwd lng="pt"><![CDATA[Benzodiazepinas]]></kwd>
<kwd lng="pt"><![CDATA[Fármacos hipnóticos]]></kwd>
<kwd lng="pt"><![CDATA[Geriatria]]></kwd>
<kwd lng="pt"><![CDATA[Cuidados de saúde primários.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huerta]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Abbing-Karahagopian]]></surname>
<given-names><![CDATA[VA]]></given-names>
</name>
<name>
<surname><![CDATA[Pequena]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Oliva]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Gardarsdottir]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exposure to benzodiazepines (anxiolytics , hypnotics and related drugs) in seven European electronic healthcare databases a cross-national descriptive study from the PROTECT-EU]]></article-title>
<source><![CDATA[Project]]></source>
<year>2016</year>
<volume>25</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>56-65</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baldwin]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Allgulander]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bandelow]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ferre]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pallanti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder]]></article-title>
<source><![CDATA[World J Biol Psychiatry]]></source>
<year>2012</year>
<volume>13</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>510-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baldwin]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Nutt]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Allgulander]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bandelow]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[den Boer]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder a revision of the 2005 guidelines from the British Association for Psychopharmacology]]></article-title>
<source><![CDATA[J Psychopharmacol]]></source>
<year>2014</year>
<volume>28</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>403-39</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anthierens]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tansens]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Petrovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Christiaens]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Qualitative insights into general practitioners views on polypharmacy]]></article-title>
<source><![CDATA[BMC Fam Pract]]></source>
<year>2010</year>
<volume>11</volume>
<page-range>65</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pek]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Remfry]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pendrith]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fan-Lun]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatia]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Soong]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults]]></article-title>
<source><![CDATA[J Hosp Med]]></source>
<year>2017</year>
<volume>12</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>310-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Batty]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigating intervention strategies to increase the appropriate use of benzodiazepines in elderly medical in-patients]]></article-title>
<source><![CDATA[Br J Clin Gov]]></source>
<year>2001</year>
<volume>6/4</volume>
<page-range>252-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lader]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines revisited will we ever learn?]]></article-title>
<source><![CDATA[Addiction]]></source>
<year>2011</year>
<volume>106</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2086-109</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>American Geriatrics Society 2012 Beers Criteria Update Expert Panel</collab>
<article-title xml:lang=""><![CDATA[American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults]]></article-title>
<source><![CDATA[J Am Geriatr Soc]]></source>
<year>2012</year>
<volume>60</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>616-31</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gray]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[LaCroix]]></surname>
<given-names><![CDATA[AZ]]></given-names>
</name>
<name>
<surname><![CDATA[Hanlon]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Penninx]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
<name>
<surname><![CDATA[Blough]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Leveille]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine use and physical disability in community-dwelling older adults]]></article-title>
<source><![CDATA[J Am Geriatr Soc]]></source>
<year>2006</year>
<volume>54</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>224-30</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woolcott]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wiens]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Marin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Meta-analysis of the impact of 9 medication classes on falls in elderly persons]]></article-title>
<source><![CDATA[Arch Intern Med]]></source>
<year>2009</year>
<volume>169</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>1952-60</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parsaik]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Mascarenhas]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Khosh-Chashm]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hashmi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[John]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Okusaga]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortality associated with anxiolytic and hypnotic drugs a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Aust N Z J Psychiatry]]></source>
<year>2016</year>
<volume>50</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>520-33</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palmaro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dupouy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lapeyre-Mestre]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines and risk of death results from two large cohort studies in France and UK]]></article-title>
<source><![CDATA[Eur Neuropsychopharmacol]]></source>
<year>2015</year>
<volume>25</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1566-77</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Canadian Agency for Drugs and Technology Health</collab>
<source><![CDATA[Discontinuation strategies for patients with long-term benzodiazepine use: a review of clinical evidence and guidelines]]></source>
<year>2015</year>
<publisher-name><![CDATA[CADTH]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>Direção-Geral da Saúde</collab>
<source><![CDATA[Tratamento sintomático da ansiedade e insónia com benzodiazepinas e fármacos análogos: norma nº 055/2011, de 27/10/2011, atualizada em 21/01/2015]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[DGS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guaiana]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Barbui]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Discontinuing benzodiazepines best practices]]></article-title>
<source><![CDATA[Epidemiol Psychiatr Sci]]></source>
<year>2016</year>
<volume>25</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>214-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neutel]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Skurtveit]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Berg]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What is the point of guidelines Benzodiazepine and z-hypnotic use by an elderly population]]></article-title>
<source><![CDATA[Sleep Med]]></source>
<year>2012</year>
<volume>13</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>893-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pottie]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Grenier]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sadowski]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Welch]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deprescribing benzodiazepine receptor agonists evidence-based clinical practice guideline]]></article-title>
<source><![CDATA[Can Fam Physician]]></source>
<year>2018</year>
<volume>64</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>339-51</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donoghue]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lader]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Usage of benzodiazepines a review]]></article-title>
<source><![CDATA[Int J Psychiatry Clin Pract]]></source>
<year>2010</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>78-87</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reeves]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guideline, education, and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison]]></article-title>
<source><![CDATA[J Correct Health Care]]></source>
<year>2012</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45-52</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gould]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Coulson]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Highton-Williamson]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Howard]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interventions for reducing benzodiazepine use in older people meta-analysis of randomised controlled trials]]></article-title>
<source><![CDATA[Br J Psychiatry]]></source>
<year>2014</year>
<volume>204</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>98-107</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Serviço Nacional de Saúde</collab>
<source><![CDATA[Bilhete de identidade dos indicadores dos cuidados de saúde primários para o ano de 2017]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[SNS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Le Couteur]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Hilmer]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deprescribing benzodiazepines in older patients impact of interventions targeting physicians, pharmacists, and patients]]></article-title>
<source><![CDATA[Drugs Aging]]></source>
<year>2018</year>
<volume>35</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>493-521</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
